E-FARMACOS Archives (by date)

• Thread Index

May 30, 2003
• [e-farmacos] Consulta sobre reaccion adversa
  • From: "Rousseau, Marcela" <marcerousseau@hotmail.com>
• [e-farmacos] Neumonia atipica
  • From: "Satue, Eduardo" <e.satue.000@recol.es>
• [e-farmacos] RAM de celecoxib y rofecoxib (cont.)
  • From: "Sanchez, Ceferino" <ceferino@ancon.up.ac.pa>
• [e-farmacos] RAM de celecoxib y rofecoxib (cont.)
  • From: "Meza, Edson" <ais@aislac.org>
May 29, 2003
• [e-farmacos] Publicidad de medicamentos, bajo la lupa (cont.)
  • From: "Zambon, Fabio" <fgzambon@yahoo.com.ar>
• [e-farmacos] Validacion de areas de acondicionamiento
  • From: "Munhoz, Pascual" <pascual@lfo.esisc.colombus.cu>
• [e-farmacos] RAM de celecoxib y rofecoxib (cont.)
  • From: "Figueras, Albert" <afs@icf.uab.es>
May 28, 2003
• [e-farmacos] Sistema de alertas rapidas
  • From: "Pal, Shanthi" <pals@who.int>
• [e-farmacos] RAM de celecoxib y rofecoxib
  • From: "Aguila, Ruben" <rubendelaguila@yahoo.com>
• [e-farmacos] Albumina y omeprazol: Protocolos (cont.)
  • From: "Domosbian, Daniel" <cimf@colfarma.org.ar>
• [e-farmacos] 4o curso de promocion de uso racional en la comunidad
  • From: "Hogerzeil, Hans" <hogerzeilh@who.int>
• [e-farmacos] Doble estandar de bayer en los 80s
  • From: "Canas. Martin" <macanas@netverk.com.ar>
May 27, 2003
• [e-farmacos] Postgrado en Farmacoeconomia y en Economia de la Salud
  • From: "Martin, Laura" <lmartin@idecb.upf.es>
• [e-farmacos] Albumina e Omeprazol Protocolos
  • From: "Oliveira, Vilberto" <voliveira@prefeitura.sp.gov.br>
• [e-farmacos] Publicidad de medicamentos, bajo la lupa
  • From: "Domosbian, Daniel" <cimf@colfarma.org.ar>
• [e-farmacos] Ensayos clinicos no autorizados en Argentina
  • From: "Canas, Martin" <macanas@netverk.com.ar>
May 26, 2003
• [e-farmacos] Misoprostol (cont.)
  • From: "Lima, Thaise" <thaiselima@ieg.com.br>
• [e-farmacos] Medicamentos y Terapeutica (cont.)
  • From: "Giron, Nora" <ngiron@bol.ops-oms.org>
• [e-farmacos] Misoprostol (cont.)
  • From: "Agusti, Antonia" <ag@icf.uab.es>
• [e-farmacos] Misoprostol (cont.)
  • From: "Alves, Giane" <gaaoliveira@prefeitura.sp.gov.br>
• [e-farmacos] Bandolera, numero 110
  • From: "Canas, Martin" <macanas@netverk.com.ar>
• [e-farmacos] Misoprostol (cont.)
  • From: "Cimf" <cimf@colfarma.org.ar>
• [e-farmacos] Brasil: patente del benznidazol y van ...(cont.)
  • From: "Canas, Martin" <macanas@netverk.com.ar>
May 22, 2003
• [e-farmacos] Carta conjunta: MSF-Oxfam-HAI a Asamblea M Salud
  • From: "Uranga, Nora" <Nora_uranga@madrid.msf.org>
• [e-farmacos] Contraindicacion de repaglinida con gemfibrozilo
  • From: "Madurga, Mariano" <mmadurga@agemed.es>
• [e-farmacos] Brasil: patente del benznidazol (cont.)
  • From: "Canas, Martin" <macanas@netverk.com.ar>
May 21, 2003
• [e-farmacos] Vacina para hepatite A (cont)
  • From: "Rey, Aida" <areyal@adinet.com.uy>
• [e-farmacos] Misoprostol (cont.)
  • From: "Rey, Aida" <areyal@adinet.com.uy>
• [e-farmacos] Medicamentos y Terapeutica
  • From: "Tassoni, Silvia" <hoteo0@rosario.gov.ar>
• [e-farmacos] Misoprostol
  • From: "Perini, Edson" <edson@farmacia.ufmg.br>
May 16, 2003
• [e-farmacos] Brasil: patente del benznidazol (cont.)
  • From: "Ravinetto, R" <Raffaella.Ravinetto@barcelona.msf.org>
• [e-farmacos] Aspirina y sindrome de Reye
  • From: "Madurga, Mariano" <mmadurga@agemed.es>
• [e-farmacos] Misoprostol
  • From: "Alves, G" <gaaoliveira@prefeitura.sp.gov.br>
• [e-farmacos] Brasil consigue patente de benznidazol
  • From: "Tavera, Maria T" <mayatavera@hotmail.com>
• [e-farmacos] : Vacina para hepatite A (cont)
  • From: "Alves, G" <gaaoliveira@prefeitura.sp.gov.br>
May 15, 2003
• [e-farmacos] JNC-7 Hypertension Treatment Guidelines
  • From: "Canas, Martin" <macanas@netverk.com.ar>
May 14, 2003
• [e-farmacos] Medicamentos Esenciales - tratamiento ceguera
  • From: "Bascones, Luis" <luisbase@telefonica.net>
• [e-farmacos] Nimesulida (cont.)
  • From: "Canas, Martin" <macanas@netverk.com.ar>
May 13, 2003
• [e-farmacos] Bandolera, numero 109
  • From: "Canas, Martin" <macanas@netverk.com.ar>
• [e-farmacos] Nueva Lista Modelo de la OMS en la web
  • From: "Hogerzeil, Hans" <hogerzeilh@who.int>
• [e-farmacos] Uso racional del medicamento (cont.)
  • From: "Mosquera, Orlando" <omosque@opita.usco.edu.co>
• [e-farmacos] Uso racional del medicamento (cont.)
  • From: "Bourdeau, Guy" <gbourdeau@ifrance.com>
• [e-farmacos] Brasil consigue la patente del benznidazol
  • From: "Canas, Martin" <macanas@netverk.com.ar>
• [e-farmacos] Azatioprina inyectable
  • From: "Domosbian, Daniel" <cimf@colfarma.org.ar>
May 11, 2003
• [e-farmacos] Lindano y neurotoxicidad (cont.)
  • From: "Vacca, Claudia" <cvaquis@hotmail.com>
• [e-farmacos] Vacuna hepatitis A
  • From: "Domosbian, Daniel" <cimf@colfarma.org.ar>
• [e-farmacos] Nimesulide (cont.)
  • From: "Oliveira, V." <voliveira@prefeitura.sp.gov.br>
• [e-farmacos] Nimesulida (cont.)
  • From: "Tassoni, Silvia" <hoteo0@rosario.gov.ar>
• [e-farmacos] Uso racional del medicamento (cont.)
  • From: "Satue, Eduardo" <e.satue.000@recol.es>
May 07, 2003
• [e-farmacos] Nimesulide
  • From: "Doylet, Leonor" <leonordoylet@becopsa.com>
• [e-farmacos] Practicas ilegales entre los laboratorios: advertencia
  • From: "Canas, Martin" <macanas@netverk.com.ar>
• [e-farmacos] Lindano y neurotoxicidad
  • From: "Madurga, Mariano" <mmadurga@agemed.es>
• [e-farmacos] Uso racional del medicamento (cont.)
  • From: "Bacherer, Lila" <prodeme@cotas.com.bo>
May 06, 2003
• [e-farmacos] Uso racional del medicamento
  • From: "FSXXI" <fsxxi@recol.es>
• [e-farmacos] Omega3 (cont.)
  • From: "Tamayo, Darina" <tamayo@marionegri.it>
May 02, 2003
• [e-farmacos] Informacion de medicamentos en los diarios
  • From: "Canas. Martin" <macanas@netverk.com.ar>
• [e-farmacos] Medicamentos y Salud v4 n1,2,3
  • From: "Canas, Martin" <macanas@netverk.com.ar>
• [e-farmacos] Pergolide y valvulopatias
  • From: "Valsecia, Mabe" <mvalsecia@med.unne.edu.ar>
• [e-farmacos] Omega3 (cont.)
  • From: "Mendivil, Jimena" <mendiviljimena@hotmail.com>
May 01, 2003
• [e-farmacos] Red internacional de guias de tratamiento
  • From: "Hogerzeil, Hans" <hogerzeilh@who.int>